• article not found
  • Filters close
    Newswise: Latest Data Shows Decreases in Cancer Diagnoses and Early-Stage Disease Continued in Second Year of COVID-19 Pandemic
    Release date: 23-Sep-2024 5:00 PM EDT
    Latest Data Shows Decreases in Cancer Diagnoses and Early-Stage Disease Continued in Second Year of COVID-19 Pandemic
    American Cancer Society (ACS)

    Using newly released cancer surveillance data, researchers at the American Cancer Society (ACS) found decreases in cancer diagnoses and proportion of early-stage diagnoses continued in 2021 in the United States during the second year of the COVID-19 pandemic. The proportion of late-stage diagnoses was lower in 2021 than in 2020, but has not returned to pre-pandemic levels. The findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

    UNREVIEWED

    Newswise: Families With a History of Cancer Face Various Types of Debt Even Years After Diagnosis, According to New Findings
    23-Sep-2024 3:05 PM EDT
    Families With a History of Cancer Face Various Types of Debt Even Years After Diagnosis, According to New Findings
    American Cancer Society (ACS)

    Patients diagnosed with major diseases, including cancer, often experience financial hardship due to high out-of-pocket medical costs in the United States. However, little is known about changes in income, wealth, and debt before and after major disease diagnoses. New data by researchers at the American Cancer Society (ACS) shows these families face various new types of debts, especially medical debt, after diagnoses. Moreover, newly diagnosed with cancer is associated with an increased likelihood of experiencing medical debt. The findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

    Newswise: Hurricane Disasters Impact Treatment and Care for Certain Lung Cancer Patients, New Study Finds
    23-Sep-2024 2:00 PM EDT
    Hurricane Disasters Impact Treatment and Care for Certain Lung Cancer Patients, New Study Finds
    American Cancer Society (ACS)

    A new study from researchers at the American Cancer Society (ACS) found that patients with stage 3 locally advanced non-small cell lung cancer (NSCLC) who received radiation treatment during a hurricane disaster were more likely to experience treatment completion delays. Researchers also reported that patients treated during a hurricane were more likely to receive higher total doses of radiation and complete more fractions. These findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

       
    Newswise: Patients Recovering From Lung Cancer Surgery Impacted by Wildfire Disasters, According to New Findings
    23-Sep-2024 10:00 AM EDT
    Patients Recovering From Lung Cancer Surgery Impacted by Wildfire Disasters, According to New Findings
    American Cancer Society (ACS)

    New research by scientists at the American Cancer Society (ACS) shows patients impacted by a wildfire disaster while recovering from lung cancer surgery have a longer in-hospital length of stay (LOS) than similar patients treated at the same facility at times when no disasters happened. The findings will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

       
    Newswise: High Healthcare Spending and Out-of-Pocket Burden for Working-age Patients Newly Diagnosed With Cancer, Latest Research Suggests
    23-Sep-2024 10:00 AM EDT
    High Healthcare Spending and Out-of-Pocket Burden for Working-age Patients Newly Diagnosed With Cancer, Latest Research Suggests
    American Cancer Society (ACS)

    New findings by researchers at the American Cancer Society (ACS) show total healthcare spending in the six months after a cancer diagnosis is considerable in the working-age population, with high out-of-pocket (OOP) costs for patients with private non-health maintenance organization (HMO) coverage. The study will be presented at the annual American Society of Clinical Oncology (ASCO) Quality Care Symposium in San Francisco, September 27 – 28, 2024.

       
    Newswise: Medicaid Coverage Helps People Improve Their Cardiovascular Health
    19-Sep-2024 9:00 AM EDT
    Medicaid Coverage Helps People Improve Their Cardiovascular Health
    University of California, Los Angeles (UCLA), Health Sciences

    Medicaid coverage had a significant impact on helping some people lower their blood pressure. The findings fill a gap left in the Oregon Health Insurance Experiment finding that Medicaid coverage leads to improved financial risk protection, better access to care, and lower mental stress, but found no impact on physical health such as blood pressure.

    Not for public release

    This news release is embargoed until 23-Sep-2024 5:00 PM EDT Released to reporters: 17-Sep-2024 2:00 PM EDT

    A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

    Not for public release

    This news release is embargoed until 23-Sep-2024 5:00 PM EDT Released to reporters: 17-Sep-2024 2:00 PM EDT

    A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

    Not for public release

    This news release is embargoed until 23-Sep-2024 5:00 PM EDT Released to reporters: 17-Sep-2024 2:00 PM EDT

    A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

    Newswise: Scientific innovation puts the future in focus
    Release date: 23-Sep-2024 4:05 PM EDT
    Scientific innovation puts the future in focus
    Argonne National Laboratory

    A broad-based look at the future of Argonne research.

    UNREVIEWED

    Newswise: Beth Walker named CEO of Ochsner Medical Center-New Orleans
    Release date: 23-Sep-2024 4:05 PM EDT
    Beth Walker named CEO of Ochsner Medical Center-New Orleans
    Ochsner Health

    Beth Walker has been named the Chief Executive Officer of Ochsner Medical Center – New Orleans, located at 1514 Jefferson Highway in New Orleans.

    UNREVIEWED

    Release date: 23-Sep-2024 3:05 PM EDT
    Potential indicators of life on other planets can be created in a lab
    University of Colorado Boulder

    Researchers find certain biosignature molecules may not indicate life is present, contrary to popular thought.

    UNREVIEWED

    Newswise: Simulating a Critical Point in Quark Gluon Fluid
    Release date: 23-Sep-2024 3:05 PM EDT
    Simulating a Critical Point in Quark Gluon Fluid
    Department of Energy, Office of Science

    Scientists are conducting experiments in search of a critical point in the Quantum Chromodynamics phase diagram. The main signatures of this point involve changes in the number of particles produced in heavy ion collisions. Modeling these observables requires an extension of the standard fluid dynamic framework. Scientists have now developed an algorithm for performing simulations of a critical fluid and tested those simulations.

    UNREVIEWED

    Newswise: Blood Cancers: Understanding Types, Symptoms, and Advances in Treatment
    Release date: 23-Sep-2024 3:05 PM EDT
    Blood Cancers: Understanding Types, Symptoms, and Advances in Treatment
    Rutgers Cancer Institute

    Claire Yun Kyoung Ryu Tiger, MD, PhD, medical oncologist in the Leukemia/Lymphoma/Hematologic Malignancies Program at Rutgers Cancer Institute and RWJBarnabas Health shares the basics about blood cancers.

    UNREVIEWED

    Newswise: Low Gravity in Space Travel Found to Weaken and Disrupt Normal Rhythm in Heart Muscle Cells
    23-Sep-2024 9:05 AM EDT
    Low Gravity in Space Travel Found to Weaken and Disrupt Normal Rhythm in Heart Muscle Cells
    Johns Hopkins Medicine

    Johns Hopkins Medicine scientists who arranged for 48 human bioengineered heart tissue samples to spend 30 days at the International Space Station report evidence that the low gravity conditions in space weakened the tissues and disrupted their normal rhythmic beats when compared to earth-bound samples from the same source.

    Newswise: schofield_creenshot-2024-02-16-at-12.42.02-PM.webp
    Release date: 23-Sep-2024 2:05 PM EDT
    Faculty in the News: Philosophy Professor Paul Schofield on Homelessness Being a ‘Unique Form of Injustice’
    Bates College

    Associate Professor of Philosophy Paul Schofield has become an expert source on the social and moral issues surrounding homelessness, writing opinion pieces on what he calls the “unique injustice” associated with being unhoused and prompting further conversation on the topic.

    UNREVIEWED

     
    Newswise: A precision-medicine initiative sponsored by the National Cancer Institute aims to improve treatment for the most common form of leukemia in adults
    Release date: 23-Sep-2024 2:05 PM EDT
    A precision-medicine initiative sponsored by the National Cancer Institute aims to improve treatment for the most common form of leukemia in adults
    University of Kansas Cancer Center

    The University of Kansas Cancer Center is part of the myeloMATCH trial, a large, coordinated effort to improve patient outcomes through targeted treatments for people with acute myeloid leukemia or myelodysplastic syndrome.

    UNREVIEWED

    Newswise: Q&A: How the Remote Hub Lab can prepare engineering students for their future careers
    Release date: 23-Sep-2024 1:05 PM EDT
    Q&A: How the Remote Hub Lab can prepare engineering students for their future careers
    University of Washington

    Rania Hussein, a University of Washington associate teaching professor in the electrical and computer engineering department, founded and leads the Remote Hub Lab, which allows students to access physical engineering equipment from anywhere in the world. Hussein can talk about how she prepares her students for their future careers and how the Remote Hub Lab can be a model for promoting equitable access to engineering education.

    UNREVIEWED

    Release date: 23-Sep-2024 1:05 PM EDT
    UC Irvine grad student training program aims to broaden access to cardiovascular care
    University of California, Irvine

    Irvine, Calif., Sept. 23, 2024 — Recent medical and biotechnology advances have helped people suffering from cardiovascular disease, the leading cause of death in the United States, but new treatments have not been distributed evenly or equitably throughout society, according to researchers at the University of California, Irvine.

    UNREVIEWED

    Newswise: Researchers say colleges barred from throwing money at student-athletes are offering them multimillion-dollar coaches instead
    Release date: 23-Sep-2024 12:45 PM EDT
    Researchers say colleges barred from throwing money at student-athletes are offering them multimillion-dollar coaches instead
    West Virginia University

    Research from Brad Humphreys and Jane Ruseski, economics professors at the West Virginia University John Chambers College of Business and Economics, has revealed college football coaches’ paychecks influence the quality of the players they’re able to recruit.

    UNREVIEWED



    close
    0.14083